Pittenger & Anderson’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$34.1K Hold
612
– – ﹤0.01% 340
2026
Q2
$33.6K Hold
612
– – ﹤0.01% 340
2026
Q1
$20.3K Hold
612
– – ﹤0.01% 363
2025
Q4
$18.2K Hold
612
– – ﹤0.01% 371
2025
Q3
$22.1K Buy
+612
New +$20.2K ﹤0.01% 338

Other funds holding TGTX

Pittenger & Anderson's TGTX Position: Q3 2026 in Review

Pittenger & Anderson held its TG Therapeutics (TGTX) position steady in Q3 2026 at 612 shares worth $34.1K. The position accounts for ﹤0.01% of the portfolio, ranked #340.

Pittenger & Anderson first reported a position in TGTX in Q3 2025 and has held it in 5 quarters since. 455 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Pittenger & Anderson held 612 shares of TG Therapeutics worth $34.1K as of Q3 2026.
  • Pittenger & Anderson left its TG Therapeutics share count unchanged in Q3 2026.
  • TG Therapeutics made up ﹤0.01% of Pittenger & Anderson's portfolio in Q3 2026, its #340 holding.
  • Pittenger & Anderson first reported a position in TG Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • 455 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Pittenger & Anderson's 13F filing for Q3 2026, filed 2 Nov 2026.